Home LiteratureArticle Details
PMID: 18947320 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Infection control and hospital epidemiology ·Vol. 29 ·No. 11 ·2008-11-00 ·Pages 996-1011

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, National Healthcare Safety Network Team, Participating National Healthcare Safety Network Facilities

Abstract

To describe the frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections (HAIs) reported by hospitals in the National Healthcare Safety Network (NHSN). Data are included on HAIs (ie, central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections) reported to the Patient Safety Component of the NHSN between January 2006 and October 2007. The results of antimicrobial susceptibility testing of up to 3 pathogenic isolates per HAI by a hospital were evaluated to define antimicrobial-resistance in the pathogenic isolates. The pooled mean proportions of pathogenic isolates interpreted as resistant to selected antimicrobial agents were calculated by type of HAI and overall. The incidence rates of specific device-associated infections were calculated for selected antimicrobial-resistant pathogens according to type of patient care area; the variability in the reported rates is described. Overall, 463 hospitals reported 1 or more HAIs: 412 (89%) were general acute care hospitals, and 309 (67%) had 200-1,000 beds. There were 28,502 HAIs reported among 25,384 patients. The 10 most common pathogens (accounting for 84% of any HAIs) were coagulase-negative staphylococci (15%), Staphylococcus aureus (15%), Enterococcus species (12%), Candida species (11%), Escherichia coli (10%), Pseudomonas aeruginosa (8%), Klebsiella pneumoniae (6%), Enterobacter species (5%), Acinetobacter baumannii (3%), and Klebsiella oxytoca (2%). The pooled mean proportion of pathogenic isolates resistant to antimicrobial agents varied significantly across types of HAI for some pathogen-antimicrobial combinations. As many as 16% of all HAIs were associated with the following multidrug-resistant pathogens: methicillin-resistant S. aureus (8% of HAIs), vancomycin-resistant Enterococcus faecium (4%), carbapenem-resistant P. aeruginosa (2%), extended-spectrum cephalosporin-resistant K. pneumoniae (1%), extended-spectrum cephalosporin-resistant E. coli (0.5%), and carbapenem-resistant A. baumannii, K. pneumoniae, K. oxytoca, and E. coli (0.5%). Nationwide, the majority of units reported no HAIs due to these antimicrobial-resistant pathogens.

MeSH Terms
Anti-Infective Agents/pharmacology Bacteria/drug effects Bacterial Infections/epidemiology,microbiology Catheter-Related Infections/epidemiology,microbiology Centers for Disease Control and Prevention, U.S. Cross Infection/epidemiology,microbiology Drug Resistance, Bacterial Drug Resistance, Multiple, Bacterial Electronic Data Processing/methods Fungi/drug effects,physiology Hospitals/statistics & numerical data Humans Mycoses/epidemiology,microbiology Pneumonia, Ventilator-Associated/epidemiology,microbiology United States/epidemiology
Chemicals
Anti-Infective Agents
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Hidron Alicia I
Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Edwards Jonathan R
Patel Jean
Horan Teresa C
Sievert Dawn M
Pollock Daniel A
Fridkin Scott K
National Healthcare Safety Network Team
Participating National Healthcare Safety Network Facilities
Article Info
Journal
Infection control and hospital epidemiology
Abbr.
Infect Control Hosp Epidemiol
ISSN
1559-6834
Published
2008-11-00
Pages
996-1011
Language
English
Region
United States
NLM ID
8804099
Subset
IM
Corrections
ErratumIn
-
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com